| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | — | -59.9% |
| R&D Expense | $24.6M | — | -22.0% |
| SG&A Expense | $8.3M | — | -14.3% |
| Operating Income | -$30.3M | — | +12.7% |
| Pre-tax Income | -$27.9M | — | +9.9% |
| Income Tax | $14K | — | -62.2% |
| Net Income | -$27.9M | — | +9.9% |
| EPS (Basic) | -$0.47 | — | +11.3% |
| EPS (Diluted) | -$0.47 | — | +11.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $43.3M | -33.7% | -42.1% |
| Short-term Investments | $98.2M | -25.1% | -39.1% |
| Accounts Receivable | $1.5M | -15.2% | -7.9% |
| Current Assets | $147.0M | -27.5% | -40.1% |
| Total Assets | $219.3M | -13.1% | -37.9% |
| Current Liabilities | $17.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.4M | — | +11.8% |
| Capital Expenditures | $14K | — | -97.9% |
| Investing Cash Flow | $8.1M | — | -80.3% |
| Financing Cash Flow | $3.3M | — | +3963.4% |
| Free Cash Flow | -$33.4M | — | +13.3% |
| -56.6% |
| Total Liabilities | $45.7M | -18.8% | -43.3% |
| Stockholders' Equity | $173.7M | -11.4% | -36.3% |